Posted 05 February 2009
The advertisement is headed “THE LATEST WEIGHT MANAGEMENT SOLUTION” and states, inter alia, that “In-vitro tests conducted on a gastrointestinal model have shown that NeOptunina reduces fat absorption by 28,3%”.
It also contains a pack shot featuring the words “clinically proven fat binder”. In essence, the complainant submitted that the in-vitro study referred to was a computer assisted model and no testing was done on animals or humans to determine whether the claims apply when used by humans. In addition, no other studies have been done on this product.
… Read the rest